Evidence map›Paper›PMID 40465163›Full record

ReviewMolecular biomedicine2025

Therapeutic effect of mesenchymal stem cells and their derived exosomes in diseases.

Yang Wang, Huanhui Wang, Jing Tan, Zhijie Cao, Qun Wang, Hongkun Wang, Shouwei Yue, Wei Li, Dong Wang

Abstract readReview
In one paragraph

Review in Molecular biomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yang Wang *Department of Rehabilitation, Binzhou Medical University Hospital, Binzhou, China.
Huanhui Wang *Binzhou Medical University, Yantai, China.
Jing TanDepartment of Ultrasound Medicine, Binzhou People's Hospital, Binzhou, China.
Zhijie CaoDepartment of Rehabilitation, Binzhou Medical University Hospital, Binzhou, China.
Qun WangDepartment of Rehabilitation, Binzhou Medical University Hospital, Binzhou, China.
Hongkun WangDepartment of Rehabilitation, Binzhou Medical University Hospital, Binzhou, China.
Shouwei YueDepartment of Physical Medicine and Rehabilitation, Qilu Hospital, Medical School of Shandong University, Jinan, China.
Wei LiDepartment of Rehabilitation, Binzhou Medical University Hospital, Binzhou, China. yishengliwei@163.com.
Dong WangDepartment of Cardiology, Binzhou Medical University Hospital, Binzhou, China. binyiwangdong@126.com.ORCID http://orcid.org/0000-0002-3859-7610

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) are multipotent stem cells characterized by their robust proliferative capacity, homing ability, differentiation potential, and low immunogenicity in vitro. MSCs can be isolated from a variety of tissues, primarily including but not limited to bone marrow, adipose tissue, umbilical cord, placenta, and dental pulp. Although there have been a large number of clinical studies on the treatment of diseases by MSCs and MSCs-derived exosomes (MSCs-EXO), the large-scale clinical application of MSCs and MSCs-EXO have been limited due to the heterogeneity of the results among various studies. This review provides a detailed description of the classification and characterization of MSCs and MSCs-EXO, as well as their extraction methods. Furthermore, this review elaborates on three key mechanisms of MSCs and MSCs-EXO: paracrine mechanisms, immunomodulatory and anti-inflammatory effects, as well as their promotion of tissue regeneration. This review also examines the role of MSCs and MSCs-EXO in cardiovascular diseases, neurological disorders, autoimmune diseases, musculoskeletal disorders, and other systemic diseases over the past five years, while discussing the challenges and difficulties associated with their clinical application. Finally, we systematically summarized and analyzed the potential causes of the various heterogeneous results currently observed. Additionally, we provided an in-depth discussion on the challenges and opportunities associated with the clinical translation of disease treatment approaches based on MSCs, MSCs-EXO, and engineered exosomes.

Indexed as

ExosomesMesenchymal Stem CellsMesenchymal Stem Cell TransplantationAnimalsHumansAutoimmune diseasesCardiovascular diseasesExosomeMesenchymal stem cellMusculoskeletal disordersNeurological disorders

Identifiers

PMID40465163
PMCPMC12137892

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.